Mangoes, mint, and papaya have found a connection in the realm of medicinal cannabis, thanks to the efforts of Biortica Agrimed, an Australian B2B cultivator of medicinal cannabis. The company has recently expanded its offerings to the Australian market and its patients by introducing 49 new varieties, examples of which include Mango Mintality and Papaya Bomb. These varieties were developed through Biortica's partnership with Apollo Green, its Canadian subsidiary.
Mango Mintality, a creation by Purple City Genetics from Oakland, California, is known for its strong growth and high yield of lime-green flowers adorned with orange pistils. It features an aroma blend of ripe mango and fresh mint, with a THC content ranging between 22 – 26% and less than 0.5% CBD. Its flowering period is 9-10 weeks, making it well-suited for indoor cultivation spaces with ample vertical room. This Indica-dominant hybrid is a cross between Gush Mints and Mango Haze.
Papaya Bomb, another Indica-dominant variety from Purple City Genetics, has gained recognition, including an award in the Ice Water Hash category at the 2022 Emerald Cup. It boasts THC levels between 24 – 28%, with some plants reaching up to 31%, and less than 0.5% CBD. The strain, a cross between Papaya and THC Bomb, has a flowering time of under 9 weeks and its aroma profile that includes notes of ripe papaya, melon, vanilla, and tropical fruits.
Tom Varga, CEO of Biortica, says that "More choices are always better. We're working to ensure patients get the broadest medicinal offering possible, year-round, and that growers are able to secure a range of genetics that best suit their situations."
For more information:
Biortica Agrimed
www.biortica.com